{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:51:56Z","timestamp":1791154316321,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41440-026-02749-8","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:21:25Z","timestamp":1785489685000},"page":"2792-2802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypertensive disorders of pregnancy and women\u2019s health throughout the life course: an update review 2025\u20132026"],"prefix":"10.1038","volume":"49","author":[{"given":"Marie","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Mito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keika","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Arata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"2749_CR1","doi-asserted-by":"publisher","unstructured":"Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Magee LA, et al. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension. 2022;79. https:\/\/doi.org\/10.1161\/HYP.0000000000000208","DOI":"10.1161\/HYP.0000000000000208"},{"key":"2749_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preghy.2021.03.001","volume":"24","author":"F Li","year":"2021","unstructured":"Li F, Wang T, Chen L, Zhang S, Chen L, Qin J. Adverse pregnancy outcomes among mothers with hypertensive disorders in pregnancy: a meta-analysis of cohort studies. Pregnancy Hypertens. 2021;24:107\u201317.","journal-title":"Pregnancy Hypertens"},{"key":"2749_CR3","doi-asserted-by":"publisher","first-page":"e0319177","DOI":"10.1371\/journal.pone.0319177","volume":"20","author":"N Maeda","year":"2025","unstructured":"Maeda N, Koyama M, Takatsuka S, Oyatani K, Himuro N, Mariya T, et al. Maternal age and the rising incidence of hypertensive disorders of pregnancy: a comprehensive analysis of national claims data from Japan. PLoS ONE. 2025;20:e0319177.","journal-title":"PLoS ONE"},{"key":"2749_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.025050","volume":"11","author":"PM Freaney","year":"2022","unstructured":"Freaney PM, Harrington K, Molsberry R, Perak AM, Wang MC, Grobman W, et al. Temporal trends in adverse pregnancy outcomes in birthing individuals aged 15 to 44 years in the United States, 2007 to 2019. J Am Heart Assoc. 2022;11:e025050.","journal-title":"J Am Heart Assoc"},{"key":"2749_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023791","volume":"11","author":"NA Cameron","year":"2022","unstructured":"Cameron NA, Everitt I, Seegmiller LE, Yee LM, Grobman WA, Khan SS. Trends in the incidence of new-onset hypertensive disorders of pregnancy among rural and urban areas in the United States, 2007 to 2019. J Am Heart Assoc. 2022;11:e023791.","journal-title":"J Am Heart Assoc"},{"key":"2749_CR6","doi-asserted-by":"publisher","first-page":"E897","DOI":"10.1503\/cmaj.231547","volume":"196","author":"S Dzakpasu","year":"2024","unstructured":"Dzakpasu S, Nelson C, Darling EK, Edwards W, Murphy PA, Scott H, et al. Trends in rate of hypertensive disorders of pregnancy and associated morbidities in Canada: a population-based study (2012\u20132021). CMAJ. 2024;196:E897\u2013E904.","journal-title":"CMAJ"},{"key":"2749_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/10641955.2023.2217452","volume":"42","author":"E Fronek","year":"2023","unstructured":"Fronek E, Martins S, Contag S. Prevalence of hypertensive disorders of pregnancy at or beyond 39 weeks gestational age and associated maternal complications. Hypertens Pregnancy. 2023;42:2217452.","journal-title":"Hypertens Pregnancy"},{"key":"2749_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1161\/HYPERTENSIONAHA.119.12968","volume":"74","author":"CV Ananth","year":"2019","unstructured":"Ananth CV, Duzyj CM, Yadava S, Schwebel M, Tita ATN, Joseph KS. Changes in the prevalence of chronic hypertension in pregnancy, United States, 1970 to 2010. Hypertension. 2019;74:1089\u201395.","journal-title":"Hypertension"},{"key":"2749_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/1471-0528.17994","volume":"132","author":"H Okubo","year":"2025","unstructured":"Okubo H, Nakayama SF, Mito A, Arata N, Ohya Y. Japan Environment and Children\u2019s Study Group. Adherence to healthy prepregnancy lifestyle and risk of adverse pregnancy outcomes: a prospective cohort study. BJOG. 2025;132:375\u201386.","journal-title":"BJOG"},{"key":"2749_CR10","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jacc.2025.02.015","volume":"85","author":"V Mathew","year":"2025","unstructured":"Mathew V, Khan RR, Jowell AR, Yan Q, Pe\u2019er I, Truong B, et al. Genetic risk and first-trimester cardiovascular health predict hypertensive disorders of pregnancy in nulliparous women. J Am Coll Cardiol. 2025;85:1488\u20131500.","journal-title":"J Am Coll Cardiol"},{"key":"2749_CR11","doi-asserted-by":"publisher","first-page":"366.e1","DOI":"10.1016\/j.ajog.2023.07.057","volume":"230","author":"M Mitsunami","year":"2024","unstructured":"Mitsunami M, Wang S, Soria-Contreras DC, Minguez-Alarcon L, Ortiz-Panozo E, Stuart JJ, et al. Pre-pregnancy plant-based diets and risk of hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2024;230:366.e1\u2013366.e19.","journal-title":"Am J Obstet Gynecol"},{"key":"2749_CR12","doi-asserted-by":"crossref","unstructured":"Raghavan R, Dreibelbis C, Kingshipp BJ, Wong YP, Terry N, Abrams B, et al. What is the relationship between dietary patterns before and during pregnancy and risk of hypertensive disorders of pregnancy? In: Dietary Patterns before and during Pregnancy and Risk of Hypertensive Disorders of Pregnancy: A Systematic Review.USDA Nutrition Evidence Systematic Review; 2019. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK579814\/.","DOI":"10.52570\/NESR.PB242018.SR0101"},{"key":"2749_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033702","volume":"13","author":"H Okubo","year":"2024","unstructured":"Okubo H, Nakayama SF, Mito A, Arata N, Kamijima M, Yamazaki S, et al. Association between periconceptional diet quality and hypertensive disorders of pregnancy: the Japan Environment and Children\u2019s study. JAHA. 2024;13:e033702.","journal-title":"JAHA"},{"key":"2749_CR14","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3390\/jcm13082198","volume":"13","author":"C Taliento","year":"2024","unstructured":"Taliento C, Piccolotti I, Sabattini A, Tormen M, Cappadona R, Greco P, et al. Effect of physical activity during pregnancy on the risk of hypertension disorders and gestational diabetes: evidence generated by new RCTs and systematic reviews. J Clin Med. 2024;13:2198.","journal-title":"J Clin Med"},{"key":"2749_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41440-024-01991-2","volume":"48","author":"M Shan","year":"2025","unstructured":"Shan M, Qiu F, Li P, Zhang Y, Shi L. Maternal exercise represses FGF21 via SIRT1 to improve the phenotypic transformation of vascular smooth muscle in hypertensive offspring. Hypertens Res. 2025;48:353\u201365.","journal-title":"Hypertens Res"},{"key":"2749_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103395","volume":"86","author":"Y Xiong","year":"2025","unstructured":"Xiong Y, Chen J, Wu Y, Zhao P, Liao M, Guo J, et al. The effect of maternal pre-pregnancy body mass index on hypertensive disorders of pregnancy (HDP): a systematic review and dose-response meta-analysis of cohort studies involving 50 million pregnancies. eClinicalMedicine. 2025;86:103395.","journal-title":"eClinicalMedicine"},{"key":"2749_CR17","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41430-021-00902-9","volume":"75","author":"N Schenkelaars","year":"2021","unstructured":"Schenkelaars N, Rousian M, Hoek J, Schoenmakers S, Willemsen S, Steegers-Theunissen R. Preconceptional maternal weight loss and hypertensive disorders in pregnancy: a systematic review and meta-analysis. Eur J Clin Nutr. 2021;75:1684\u201397.","journal-title":"Eur J Clin Nutr"},{"key":"2749_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.fertnstert.2024.02.038","volume":"122","author":"AE Caldwell","year":"2024","unstructured":"Caldwell AE, Gorczyca AM, Bradford AP, Nicklas JM, Montgomery RN, Smyth H, et al. Effectiveness of preconception weight loss interventions on fertility in women: a systematic review and meta-analysis. Fertil Steril. 2024;122:326\u201340.","journal-title":"Fertil Steril"},{"key":"2749_CR19","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s43032-023-01222-y","volume":"30","author":"Z-R Ye","year":"2023","unstructured":"Ye Z-R, Yan C-Q, Liao N, Wen S-H. The effectiveness and safety of exenatide versus metformin in patients with polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Reprod Sci. 2023;30:2349\u201361.","journal-title":"Reprod Sci"},{"key":"2749_CR20","doi-asserted-by":"publisher","first-page":"116.e1","DOI":"10.1016\/j.ajog.2025.01.019","volume":"233","author":"MR Imbroane","year":"2025","unstructured":"Imbroane MR, LeMoine F, Nau CT. Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes. Am J Obstet Gynecol. 2025;233:116.e1\u2013116.e7.","journal-title":"Am J Obstet Gynecol"},{"key":"2749_CR21","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1001\/jama.2025.20951","volume":"334","author":"J Maya","year":"2025","unstructured":"Maya J, Pant D, Fu Y, James K, Batlle C, Hsu S, et al. Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation. JAMA. 2025;334:2186\u201396.","journal-title":"JAMA"},{"key":"2749_CR22","doi-asserted-by":"publisher","unstructured":"Dao K, Shechtman S, Weber-Schoendorfer C, Diav-Citrin O, Murad RH, Berlin M, et al. Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services. 2024. https:\/\/doi.org\/10.1136\/bmjopen-2023-083550.","DOI":"10.1136\/bmjopen-2023-083550"},{"key":"2749_CR23","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/bcp.16354","volume":"91","author":"J Zhou","year":"2025","unstructured":"Zhou J, Wei Z, Lai W, Liu M, Wu X. The safety profile of usage of glucagon-like peptide-1 receptor agonists in pregnancy: a pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System. Br J Clin Pharmacol. 2025;91:1272\u201380.","journal-title":"Br J Clin Pharmacol"},{"key":"2749_CR24","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41366-025-01748-y","volume":"49","author":"D Kurnaz","year":"2025","unstructured":"Kurnaz D, Kara\u00e7am Z. The effect of methods used in the management of maternal obesity on pregnancy and birth outcomes: a systematic review with meta-analysis. Int J Obes. 2025;49:1013\u201323.","journal-title":"Int J Obes"},{"key":"2749_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01976-y","volume":"11","author":"S Tano","year":"2021","unstructured":"Tano S, Kotani T, Ushida T, Yoshihara M, Imai K, Nakano-Kobayashi T, et al. Annual body mass index gain and risk of hypertensive disorders of pregnancy in a subsequent pregnancy. Sci Rep. 2021;11:22519.","journal-title":"Sci Rep"},{"key":"2749_CR26","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41440-024-02024-8","volume":"48","author":"S Tano","year":"2025","unstructured":"Tano S, Kotani T, Ushida T, Matsuo S, Yoshihara M, Imai K, et al. Visualizing risk modification of hypertensive disorders of pregnancy: development and validation of prediction model for personalized interpregnancy weight management. Hypertens Res. 2025;48:884\u201393.","journal-title":"Hypertens Res"},{"key":"2749_CR27","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.fertnstert.2021.08.018","volume":"116","author":"A Penzias","year":"2021","unstructured":"Penzias A, Azziz R, Bendikson K, Falcone T, Hansen K, Hill M, et al. Obesity and reproduction: a committee opinion. Fertil Steril. 2021;116:1266\u201385.","journal-title":"Fertil Steril"},{"key":"2749_CR28","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2025.40.e302","volume":"40","author":"YJ Jung","year":"2025","unstructured":"Jung YJ, Kim T, Kim Y-H. Elevated pre-pregnancy blood pressure and the risk of adverse pregnancy outcomes: evidence from a nationwide population-based study. J Korean Med Sci. 2025;40:e302.","journal-title":"J Korean Med Sci"},{"key":"2749_CR29","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1161\/HYPERTENSIONAHA.123.22296","volume":"81","author":"W Xiong","year":"2024","unstructured":"Xiong W, Han L, Tang X, Wang Q, Chen W, Li R, et al. Preconception blood pressure and adverse pregnancy outcomes: a population-based cohort study. Hypertension. 2024;81:e31\u2013e40.","journal-title":"Hypertension"},{"key":"2749_CR30","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41440-020-0438-9","volume":"43","author":"N Li","year":"2020","unstructured":"Li N, An H, Li Z, Ye R, Zhang L, Li H, et al. Preconception blood pressure and risk of gestational hypertension and preeclampsia: a large cohort study in China. Hypertens Res. 2020;43:956\u201362.","journal-title":"Hypertens Res"},{"key":"2749_CR31","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","volume":"386","author":"AT Tita","year":"2022","unstructured":"Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, et al. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022;386:1781\u201392.","journal-title":"N Engl J Med"},{"key":"2749_CR32","unstructured":"Clinical Guidance for the Integration of the Findings of the Chronic Hypertension and Pregnancy (CHAP) Study. 2025. https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2022\/04\/clinical-guidance-for-the-integration-of-the-findings-of-the-chronic-hypertension-and-pregnancy-chap-study."},{"key":"2749_CR33","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur Heart J. 2024;45:3912\u20134018.","journal-title":"Eur Heart J"},{"key":"2749_CR34","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/AOG.0000000000005410","volume":"142","author":"E Bailey","year":"2023","unstructured":"Bailey E, Tita ATN, Leach J, Boggess K, Dugoff L, Sibai B, et al. Perinatal outcomes associated with management of stage 1 hypertension. Obstet Gynecol. 2023;142:1395\u2013404.","journal-title":"Obstet Gynecol"},{"key":"2749_CR35","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1038\/s41440-024-01830-4","volume":"47","author":"W Espeche","year":"2024","unstructured":"Espeche W, Minetto J, Leiva Sisnieguez CE, Cerri G, Carrera Ramos P, Olano D, et al. Time in therapeutic range and risk of preeclampsia in chronic hypertensive pregnant women. Hypertens Res. 2024;47:2895\u2013901.","journal-title":"Hypertens Res"},{"key":"2749_CR36","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/s41440-025-02239-3","volume":"48","author":"M Abe","year":"2025","unstructured":"Abe M, Shinohara Y, Arata N, Metoki H, Fukami A, Arima H, et al. Blood pressure-lowering treatment for pregnant women with non-severe hypertension: a systematic review and meta-analysis. Hypertens Res. 2025;48:2152\u201362.","journal-title":"Hypertens Res"},{"key":"2749_CR37","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1161\/HYPERTENSIONAHA.123.22584","volume":"81","author":"P Guerby","year":"2024","unstructured":"Guerby P, Audibert F, Johnson J-A, Okun N, Gigu\u00e8re Y, Forest J-C, et al. Prospective validation of first-trimester screening for preterm preeclampsia in nulliparous women (PREDICTION study). Hypertension. 2024;81:1574\u201382.","journal-title":"Hypertension"},{"key":"2749_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2024.101136","volume":"37","author":"K Harris","year":"2024","unstructured":"Harris K, Xu L, Woodward M, De Kat A, Zhou X, Shang J, et al. Early pregnancy maternal blood pressure and risk of preeclampsia: does the association differ by parity? Evidence from 14,086 women across 7 countries. Pregnancy Hypertens. 2024;37:101136.","journal-title":"Pregnancy Hypertens"},{"key":"2749_CR39","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/HJH.0000000000003472","volume":"41","author":"F Piani","year":"2023","unstructured":"Piani F, Agnoletti D, Baracchi A, Scarduelli S, Verde C, Tossetta G, et al. Serum uric acid to creatinine ratio and risk of preeclampsia and adverse pregnancy outcomes. J Hypertens. 2023;41:1333\u20138.","journal-title":"J Hypertens"},{"key":"2749_CR40","doi-asserted-by":"publisher","first-page":"EVIDoa2200161","DOI":"10.1056\/EVIDoa2200161","volume":"1","author":"R Thadhani","year":"2022","unstructured":"Thadhani R, Lemoine E, Rana S, Costantine MM, Calsavara VF, Boggess K, et al. Circulating angiogenic factor levels in hypertensive disorders of pregnancy. NEJM Evid. 2022;1:EVIDoa2200161.","journal-title":"NEJM Evid"},{"key":"2749_CR41","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","volume":"74","author":"AS Cerdeira","year":"2019","unstructured":"Cerdeira AS, O\u2019Sullivan J, Ohuma EO, Harrington D, Szafranski P, Black R, et al. Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia. Hypertension. 2019;74:983\u201390.","journal-title":"Hypertension"},{"key":"2749_CR42","doi-asserted-by":"publisher","first-page":"317.e1","DOI":"10.1016\/j.ajog.2024.06.010","volume":"232","author":"CRPD Reis","year":"2025","unstructured":"Reis CRPD, O\u2019Sullivan J, Ohuma EO, James T, Papageorghiou AT, Vatish M, Cerdeira AS. The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia: a secondary analysis of the INSPIRE trial. Am J Obstet Gynecol. 2025;232:317.e1\u2013317.e17.","journal-title":"Am J Obstet Gynecol"},{"key":"2749_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejogrb.2024.07.023","volume":"300","author":"S Shinohara","year":"2024","unstructured":"Shinohara S, Hiraoka N, Mochizuki K, Yasuda G, Kasai M, Sunami R. sFlt-1\/PlGF ratio predicts serious outcomes in confirmed early-onset preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2024;300:159\u201363.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2749_CR44","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/s41440-023-01509-2","volume":"47","author":"Y Chen","year":"2024","unstructured":"Chen Y, Di X, Xiang G, Liu Y, Pan X, Deng W, et al. sFlt-1\/PlGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development. Hypertens Res. 2024;47:849\u201358.","journal-title":"Hypertens Res"},{"key":"2749_CR45","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1161\/HYPERTENSIONAHA.124.23411","volume":"81","author":"N Melamed","year":"2024","unstructured":"Melamed N, Kingdom JC, Fu L, Yip PM, Arruda-Caycho I, Hui D, et al. Predictive and diagnostic value of the angiogenic proteins in patients with chronic kidney disease. Hypertension. 2024;81:2251\u201362.","journal-title":"Hypertension"},{"key":"2749_CR46","doi-asserted-by":"crossref","unstructured":"Takagi K, Nakamoto O, Watanabe K, Tanaka K, Matsubara K, Kawabata I, et al. A Review of the Best Practice Guide 2021 for the Diagnosis and Management of Hypertensive Disorders of Pregnancy (HDP). Hypertens Res Pregnancy. 2022;10:57\u201373.","DOI":"10.14390\/jsshp.10.57"},{"key":"2749_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","volume":"74","author":"X Bian","year":"2019","unstructured":"Bian X, Biswas A, Huang X, Lee KJ, Li TK-T, Masuyama H, et al. Short-term prediction of adverse outcomes using the sFlt-1 (soluble FMS-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio in Asian women with suspected preeclampsia. Hypertension. 2019;74:164\u201372.","journal-title":"Hypertension"},{"key":"2749_CR48","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/s41440-021-00629-x","volume":"44","author":"A Ohkuchi","year":"2021","unstructured":"Ohkuchi A, Saito S, Yamamoto T, Minakami H, Masuyama H, Kumasawa K, et al. Short-term prediction of preeclampsia using the sFlt-1\/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study. Hypertens Res. 2021;44:813\u201321.","journal-title":"Hypertens Res"},{"key":"2749_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.xagr.2024.100359","volume":"4","author":"E Patel","year":"2024","unstructured":"Patel E, Suresh S, Mueller A, Bisson C, Zhu K, Verlohren S, et al. sFlt1\/PlGF among patients with suspected preeclampsia when considering hypertensive status. AJOG Glob Rep. 2024;4:100359.","journal-title":"AJOG Glob Rep"},{"key":"2749_CR50","doi-asserted-by":"publisher","first-page":"385.e1","DOI":"10.1016\/j.ajog.2024.07.015","volume":"232","author":"LP Burns","year":"2025","unstructured":"Burns LP, Potchileev S, Mueller A, Azzi M, Premkumar A, Peterson J, et al. Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1\/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2025;232:385.e1\u2013385.e21.","journal-title":"Am J Obstet Gynecol"},{"key":"2749_CR51","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1161\/HYPERTENSIONAHA.125.24649","volume":"82","author":"JM Roberts","year":"2025","unstructured":"Roberts JM, Alexeeff SE, Sun B, Greenberg M, King A, Nguyen-Huynh MN, et al. Early pregnancy blood pressure trajectories and hypertension years after pregnancy. Hypertension. 2025;82:e75\u2013e87.","journal-title":"Hypertension"},{"key":"2749_CR52","unstructured":"Recommendations. Hypertension in pregnancy: diagnosis and management. Guidance. NICE. 2019. https:\/\/www.nice.org.uk\/guidance\/ng133\/chapter\/recommendations."},{"key":"2749_CR53","doi-asserted-by":"crossref","unstructured":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135:e237\u2013e260.","DOI":"10.1097\/AOG.0000000000003891"},{"key":"2749_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148\u201369.","journal-title":"Pregnancy Hypertens"},{"key":"2749_CR55","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/CIRCULATIONAHA.124.069907","volume":"150","author":"L Nguyen-Hoang","year":"2024","unstructured":"Nguyen-Hoang L, Dinh LT, Tai AST, Nguyen D-A, Pooh RK, Shiozaki A, et al. Implementation of first-trimester screening and prevention of preeclampsia: a stepped wedge cluster-randomized trial in Asia. Circulation. 2024;150:1223\u201335.","journal-title":"Circulation"},{"key":"2749_CR56","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/jch.14821","volume":"26","author":"X Hu","year":"2024","unstructured":"Hu X, Chen D, Wang H, Lv Y, Wang Y, Gao X, et al. The optimal dosage of aspirin for preventing preeclampsia in high-risk pregnant women: a network meta-analysis of 23 randomized controlled trials. J Clin Hypertens. 2024;26:455\u201364.","journal-title":"J Clin Hypertens"},{"key":"2749_CR57","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12872-025-04941-z","volume":"25","author":"P Asiimwe","year":"2025","unstructured":"Asiimwe P, Nambozi G, Brennaman L, Ngonzi J, Ruzaaza G. Effectiveness of low-dose aspirin in reducing the risk of preeclampsia in women with chronic hypertension: an integrative literature review. BMC Cardiovasc Disord. 2025;25:554.","journal-title":"BMC Cardiovasc Disord"},{"key":"2749_CR58","doi-asserted-by":"publisher","first-page":"315.e1","DOI":"10.1016\/j.ajog.2024.06.038","volume":"232","author":"FH Amro","year":"2025","unstructured":"Amro FH, Blackwell SC, Pedroza C, Backley S, Bitar G, Daye N, et al. Aspirin 162 mg vs 81 mg for preeclampsia prophylaxis in high-risk obese individuals: a comparative effectiveness open-label randomized trial (ASPREO). Am J Obstet Gynecol. 2025;232:315.e1\u2013315.e8.","journal-title":"Am J Obstet Gynecol"},{"key":"2749_CR59","doi-asserted-by":"publisher","unstructured":"M\u00e9sz\u00e1ros B, Veres DS, Nagyist\u00f3k L, Somogyi A, Rosta K, Herold Z, et al. Pravastatin in preeclampsia: a meta-analysis and systematic review. Front Med. 2023;9. https:\/\/doi.org\/10.3389\/fmed.2022.1076372.","DOI":"10.3389\/fmed.2022.1076372"},{"key":"2749_CR60","doi-asserted-by":"publisher","first-page":"101260","DOI":"10.1016\/j.ajogmf.2023.101260","volume":"6","author":"H Provinciatto","year":"2024","unstructured":"Provinciatto H, Barbalho ME, Almeida J, Provinciatto A, Philip CE. The role of pravastatin in preventing preeclampsia in high-risk pregnant women: a meta-analysis with trial sequential analysis. Am J Obstet Gynecol MFM. 2024;6:101260.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"2749_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-025-07967-5","volume":"25","author":"P Khalili","year":"2025","unstructured":"Khalili P, Zhong Z, Peng Y. The role of statins during pregnancy on maternal risk of preeclampsia: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2025;25:841.","journal-title":"BMC Pregnancy Childbirth"},{"key":"2749_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.amjmed.2022.08.029","volume":"136","author":"IG Poornima","year":"2023","unstructured":"Poornima IG, Pulipati VP, Brinton EA, Wild RA. Update on statin use in pregnancy. Am J Med. 2023;136:12\u201314.","journal-title":"Am J Med"},{"key":"2749_CR63","doi-asserted-by":"publisher","first-page":"S1171","DOI":"10.1016\/j.ajog.2020.08.040","volume":"226","author":"DD Smith","year":"2022","unstructured":"Smith DD, Costantine MM. The role of statins in the prevention of preeclampsia. Am J Obstet Gynecol. 2022;226:S1171\u201381.","journal-title":"Am J Obstet Gynecol"},{"key":"2749_CR64","unstructured":"FDA. Statins: Drug Safety Communication - FDA Requests Removal of Strongest Warning Against Using Cholesterol-lowering Statins During Pregnancy. 2024. https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/statins-drug-safety-communication-fda-requests-removal-strongest-warning-against-using-cholesterol."},{"key":"2749_CR65","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jamacardio.2024.1389","volume":"9","author":"A Hauspurg","year":"2024","unstructured":"Hauspurg A, Venkatakrishnan K, Collins L, Countouris M, Larkin J, Quinn B, et al. Postpartum ambulatory blood pressure patterns following new-onset hypertensive disorders of pregnancy. JAMA Cardiol. 2024;9:703\u201311.","journal-title":"JAMA Cardiol"},{"key":"2749_CR66","doi-asserted-by":"publisher","first-page":"101617","DOI":"10.1016\/j.jacadv.2025.101617","volume":"4","author":"EB Rosenfeld","year":"2025","unstructured":"Rosenfeld EB, Sagaram D, Lee R, Sadural E, Miller RC, Lin R, et al. Management of Postpartum Preeclampsia and Hypertensive Disorders (MOPP): postpartum tight vs standard blood pressure control. JACC Adv. 2025;4:101617.","journal-title":"JACC Adv"},{"key":"2749_CR67","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.123.067597","volume":"149","author":"J Kitt","year":"2024","unstructured":"Kitt J, Krasner S, Barr L, Frost A, Tucker K, Bateman PA, et al. Cardiac remodeling after hypertensive pregnancy following physician-optimized blood pressure self-management: the POP-HT randomized clinical trial imaging substudy. Circulation. 2024;149:529\u201341.","journal-title":"Circulation"},{"key":"2749_CR68","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1001\/jama.2023.21523","volume":"330","author":"J Kitt","year":"2023","unstructured":"Kitt J, Fox R, Frost A, Shanyinde M, Tucker K, Bateman PA, et al. Long-term blood pressure control after hypertensive pregnancy following physician-optimized self-management: the POP-HT randomized clinical trial. JAMA. 2023;330:1991\u20139.","journal-title":"JAMA"},{"key":"2749_CR69","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/AOG.0000000000005665","volume":"144","author":"LS Lemon","year":"2024","unstructured":"Lemon LS, Quinn B, Binstock A, Larkin JC, Simhan HN, Hauspurg A. Clinical outcomes associated with a remote postpartum hypertension monitoring program. Obstet Gynecol. 2024;144:377.","journal-title":"Obstet Gynecol"},{"key":"2749_CR70","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.034031","volume":"13","author":"E Mujic","year":"2024","unstructured":"Mujic E, Parker SE, Nelson KP, O\u2019Brien M, Chestnut IA, Abrams J, et al. Implementation of a cell-enabled remote blood pressure monitoring program during the postpartum period at a safety-net hospital. J Am Heart Assoc. 2024;13:e034031.","journal-title":"J Am Heart Assoc"},{"key":"2749_CR71","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/HJH.0000000000003995","volume":"43","author":"LW Voskamp","year":"2025","unstructured":"Voskamp LW, Rousian M, Koerts JJ, Steegers-Theunissen RPM, Danser AHJ, Verdonk K. Risk factors for chronic hypertension 5\u200ayears after a pregnancy complicated by preeclampsia: a systematic review and meta-analysis. J Hypertens. 2025;43:939\u201348.","journal-title":"J Hypertens"},{"key":"2749_CR72","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.116.003497","volume":"10","author":"P Wu","year":"2017","unstructured":"Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10:e003497.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2749_CR73","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1093\/eurheartj\/ehaf565","volume":"46","author":"S Taageby Nielsen","year":"2025","unstructured":"Taageby Nielsen S, Luo J, Tybj\u00e6rg-Hansen A, Iversen K, Bundgaard H, Qvist Thomassen J, et al. Preeclampsia, gestational hypertension, and cardiovascular disease risk: a genetic epidemiological study. Eur Heart J. 2025;46:4316\u201325.","journal-title":"Eur Heart J"},{"key":"2749_CR74","first-page":"833","volume":"32","author":"H Chen","year":"2025","unstructured":"Chen H, Li R, Liu S, Zhao S, Guo T, Tian S, et al. Life\u2019s Essential 8 and cardiovascular disease in women with a history of adverse pregnancy outcomes. Eur J Prev Cardiol. 2025;32:833\u201342.","journal-title":"Eur J Prev Cardiol"},{"key":"2749_CR75","doi-asserted-by":"publisher","unstructured":"Lewey J, Beckie TM, Brown HL, Brown SD, Garovic VD, Khan SS, et al. Opportunities in the postpartum period to reduce cardiovascular disease risk after adverse pregnancy outcomes: a scientific statement from the American Heart Association. Circulation. 2024;149. https:\/\/doi.org\/10.1161\/CIR.0000000000001212.","DOI":"10.1161\/CIR.0000000000001212"},{"key":"2749_CR76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.14390\/jsshp.HRP2024-007","volume":"12","author":"Y Chigusa","year":"2024","unstructured":"Chigusa Y, Mito A, Maki S, Mimura K, Nanjo S, Yamaguchi M, et al. Health care provider system for hypertensive disorders of pregnancy in Japan. Hypertens Res Pregnancy. 2024;12:53\u20137.","journal-title":"Hypertens Res Pregnancy"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02749-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:02:23Z","timestamp":1791151343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02749-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2749"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02749-8","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}